Drug intelligence / Profile preview

Yimu Fuyan Granules

Development stage
Unknown
Lead developer
Jianmin Pharmaceutical Group
Modality
Small Molecules
Administration
Oral
01

Overview

Yimu Fuyan Granules is a Traditional Chinese Medicine (TCM) developed and manufactured by Jianmin Pharmaceutical Group. It is primarily indicated for the treatment of gynecological conditions, specifically chronic pelvic inflammatory disease (PID) and chronic pelvic pain. The formulation is composed of several herbal ingredients, including *Leonurus japonicus* (Motherwort), *Salvia miltiorrhiza* (Danshen), *Paeonia lactiflora* (Red Peony Root), *Cyperus rotundus*, and *Corydalis yanhusuo*. According to TCM principles, the drug works by promoting blood circulation, resolving blood stasis, clearing heat, and alleviating pain. Pharmacologically, it has been shown to exert anti-inflammatory and analgesic effects, likely through the modulation of inflammatory cytokines and improvement of local microcirculation in the pelvic cavity. It is widely used in China as a standard treatment for patients presenting with symptoms of damp-heat stasis, such as lower abdominal pain and lumbosacral soreness.

Brand names
Yimu Fuyan Granules
Other names
Yimu Fuyan Keli益母复炎颗粒
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Yimu Fuyan Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yimu Fuyan Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call